Free Trial

Julien Ouaddour Analyst Performance

Analyst at Bank of America

Julien Ouaddour is a stock analyst at Bank of America in the medical sector, covering 1 publicly traded companies. Over the past year, Julien Ouaddour has issued 1 stock ratings, including and sell recommendations. While full access to Julien Ouaddour's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Julien Ouaddour's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
1 Last 0 Years
Buy Recommendations
0.00% 0 Buy Ratings
Companies Covered
1 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy0.0%0 ratings
Hold0.0%0 ratings
Sell100.0%1 ratings

the majority (100.0%) have been Sell recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
100.0% of companies on NYSE
1 company

Julien Ouaddour, an analyst at Bank of America, currently covers 1 companies listed on , with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
100.0%

Julien Ouaddour of Bank of America specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
1 company
100.0%

Julien Ouaddour's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Alcon stock logo
ALC
Alcon
12/11/2025Reiterated Rating$80.20$75.00Underperform